Donald Trump’s second administration has advanced an avalanche of policy action and political pronouncements that have jolted Washington and, in some cases, the world.

Medera, Inc., (“Medera”), a clinical-stage biotechnology company, announced today that the management team will participate ...

An advocacy group criticizes Hims & Hers Health for allegedly misleading Super Bowl ad promoting weight loss products, violating FDA regulations. Read more here.

Gain’s lead program in Parkinson’s disease has been awarded funding support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Silverstein Foundation for Parkinson’s with GBA, ...

Readers worry that fraud may tarnish the field and slow the race for a cure. Also: Charles Blow’s farewell; treatment for ...

In Fernando Rico’s home studio in Madison, however, chance is a welcome guest, a co-conspirator. Instead of planning each ...

Zenocutuzumab helps fill an important need for patients with advanced pancreatic cancer and NSCLC with NRG1 gene fusions, said Alison Schram M.D., ...

I f you're planning a Super Bowl party this weekend and thought you don't have enough AI-generated content to support it, ...

Beitler is completing his first term on the county Board of Commissioners after previously serving two terms as a Lower Macungie commissioner.

Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., Appeal Nos. 2024-1965, -1966, -2082, -2083 (Fed. Cir. Jan. 29, 2025) ...

Cortigent, Inc. (CRTG) expects to raise $15 million in an initial public offering (IPO) on Friday, February 14th, IPO Scoop reports. The company will be issuing 1,500,000 shares at $10.00 per share.

The CISA and FDA have released security warnings about the Contec CMS8000, which is used for patient monitoring.